Dr Ngozwana is CEO of Kiara Health, a South African based Africa-focused healthcare company. He is an international expert on the African Pharmaceutical industry and has worked with both the private and global public health organizations. He consulted to the World Health Organization (WHO), United Nations Industrial Development Organization (UNIDO) and the United States Pharmacopeia Convention (USP). He co-authored the Pharmaceutical Manufacturing Plan for Africa. The plan was the output of the extensive research and analytical work he conducted on the African pharmaceutical industry. He co-authored the Ethiopian Pharmaceutical Sector Strategy and Action Plan and the pharmaceutical sector strategies of several countries. He consulted for USP on their Africa strategy and authored a Thought Leadership Paper titled, The Next Frontiers for the Public Health Medicines Market: Rethinking Priorities for Improved Access to Quality-Assured Medicines for Universal Access.
He holds several board positions, including Chairman of the board of Directors of Biovac (a South African Vaccine manufacturer), Foundation NEXT (www.next2people.org); the Federation of the African Pharmaceutical Manufacturers Association and Clinical Trials Advisory Committee of the African Academy of Sciences. He is the past chairman of the National Association of Pharmaceutical Manufacturers of South Africa (NAPM), and the Southern African Generic Medicines Association. He is passionate about the development of the African pharmaceutical industry; access to quality assured medicines and has made significant contributions in developing the Industry. Dr Ngozwana holds qualifications in Medicine, Medical Pharmacology and Business Administration.